Erectile Dysfunction Prevelance Forecasts in 29 Major Markets 2017-2027 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Erectile Dysfunction Forecast in 29 Major Markets 2017-2027" report to their offering.

Erectile dysfunction, also known as ED and impotence, is defined as the frequent inability to achieve or maintain an erection sufficient for sexual activity to take place.

This report provides the current prevalent population for Erectile Dysfunction across 29 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Netherlands, Portugal, Switzerland, Croatia, Poland, Romania, Russia, Norway, Sweden, Greece, Turkey, Saudi Arabia, Egypt, China, Japan, South Korea, India, Australia, South Africa, Brazil, Mexico, Argentina) split 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Erectile Dysfunction have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Erectile Dysfunction disease include:

- Chronic heart disease

- Hypertension

- Diabetes

- BPH

- Anaemia

- Depression

- Loss of libido

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key comorbid conditions/Features associated with the disease

8. Methodology for quantification of patient numbers

9. Top-line prevalence for Erectile Dysfunction

10. Features of Erectile Dysfunction patients

11. Abbreviations used in the report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/smxk5c/erectile

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Sexual and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Sexual and Reproductive Health Drugs